Tesamorelin is the growth hormone peptide with the strongest evidence behind it. It is registered as a medicine in some countries for one specific job: reducing deep belly fat. This guide explains what the trials showed, how it differs from taking growth hormone, and which of our tesamorelin options fits your research.
Tesamorelin in 60 seconds
- Tesamorelin is a stabilised copy of GHRH, the brain’s signal to release growth hormone.
- In large human trials, 2mg a day cut visceral (deep abdominal) fat by about 15% over six months.
- It raises your own growth hormone and IGF-1 rather than adding growth hormone from outside.
What the trials showed
Tesamorelin was studied in two large randomised trials in people with excess abdominal fat linked to HIV treatment. At 2mg a day for 26 weeks, visceral fat fell by roughly 15% against a small rise on placebo, while the fat under the skin barely changed. That selectivity for deep fat is what makes it unusual. Later work also found a reduction in liver fat.
Those trials were in a specific group of patients, so the results cannot simply be copied to everyone. They are still far more than most peptides can point to.
Tesamorelin vs growth hormone
| Tesamorelin | Growth hormone (somatropin) | |
|---|---|---|
| How it works | Tells your pituitary to release more of its own | Adds growth hormone directly |
| Natural pulses | Kept | Replaced by the injected dose |
| Human trial data | Large trials for visceral fat | Extensive, for deficiency |
Which option fits
- 2mg self-mix vials (Nova Labs or UPA Labs): one vial is one trial-sized daily dose. Lowest commitment.
- 10mg pen (Noventra Pharma): 200 clicks of 50mcg, no mixing, good for daily use over weeks.
- Shredded pen: tesamorelin combined with AOD-9604 and MOTS-c, for fat-loss research that wants all three.
Side effects reported in trials
The most common were redness or itching at the injection site, joint and muscle aches, and some swelling in the hands or feet. Tesamorelin can raise blood sugar, so it matters for anyone who already watches theirs. It is not for use during pregnancy or by anyone with an active cancer.
Tesamorelin we stock
Frequently asked questions
Is tesamorelin the same as Egrifta?
Egrifta is the brand name of the registered medicine. The vials and pen we sell contain tesamorelin as a research compound and are not Egrifta.
How much tesamorelin was used in the trials?
2mg injected under the skin once a day. Most visceral fat studies ran for 26 weeks.
Does tesamorelin suppress appetite?
No. It works through growth hormone, not appetite. That is why it is often researched alongside GLP-1 peptides rather than instead of them.
Is a tesamorelin pen better than a vial?
The pen needs no mixing and doses by the click. Vials cost less per milligram but you mix them yourself. The compound is the same.
Sources
- Falutz J et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. New England Journal of Medicine, 2007. doi.org/10.1056/NEJMoa072375
- Stanley TL et al. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV, 2019. doi.org/10.1016/S2352-3018(19)30338-8
Everything we sell is supplied for research use only and is not a registered medicine. Nothing here is medical advice.
Browsing by goal? See peptides for muscle growth.
Related reading: HGH peptides and growth hormone.
More on fat loss outside the GLP-1s: fat-loss peptides that are not GLP-1s.

